article thumbnail

November 2023 Regulatory Compliance Updates

Verisys

– The best resource for monthly healthcare regulatory compliance updates. Compliance Updates: November 2023 Here is our monthly regulatory update. A big thanks to our compliance team, who monitors state, federal, and international updates. See below for changes from several states introducing legislation.

article thumbnail

OIG and CMS Audits Present New Round of Compliance Concerns for Healthcare Providers

McBrayer Law Blog

COVID-19 has placed enormous stress on our healthcare system. Federal and state responses to COVID-19 have woven a complex and complicated safety net by easing regulatory requirements through waivers and funneling billions of dollars to providers among many other actions.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

California Consumer Privacy Act can cause headaches for healthcare orgs

Healthcare It News

After interviewing 19 digital privacy and information system experts, researchers found that professionals perceived legal and technological challenges for healthcare organizations in complying with CCPA. The high cost of compliance without an equitable ROI. WHY IT MATTERS. Lack of sophisticated and robust digital infrastructure.

HIPAA 292
article thumbnail

Leveraging Technology to Bridge Gaps in Compliance

HIT Consultant

Sean Eaton, Senior Compliance Solutions Specialist at GHX American health systems, hospitals and post-acute care providers are required to comply with hundreds of regulatory requirements. Facilitating this compliance comes with a high cost. million annually on administrative activities to support regulatory compliance.

article thumbnail

COVID-19 Treatments: Regeneron Antibody Cocktail

Exeed Regulatory Compliance

A “cocktail” of two potent monoclonal antibodies from Regeneron could be a breakthrough early intervention for COVID-19. COVID-19 has already claimed more than 220,000 lives, and as new cases continue to rise each day, there is fresh concern about many more lives at risk in the coming weeks. CONTACT US.

article thumbnail

COVID-19 Treatments: Remdesivir Antiviral Drug

Exeed Regulatory Compliance

A double-blinded, placebo-controlled, randomized clinical trial provides support for FDA approval of Remdesivir for treating COVID-19. COVID-19 continues to cause damage to both the public health and the economy at large. There is some good news on the horizon. There is some good news on the horizon. CONTACT US.

article thumbnail

COVID-19 Testing – Understanding Antibody Tests

Exeed Regulatory Compliance

Antibody tests are a powerful tool to help fight COVID-19. The COVID-19 pandemic has hit us hard. When someone has COVID-19, their immune system responds with antibodies to fight the SARS-CoV-2 Coronavirus that causes this disease. Here is a quick overview of how they work and their accuracy.